Latest news
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - The Manila TimesThe Manila Times · Sat, 08 Aug 2026 08:04:32 GMTSatellite Bio Announces FDA Clearance of IND Application for SB-101 for the Treatment of Urea Cycle Disorders (UCDs) Marking its Transition to a Clinical-Stage Biotechnology Company - BioSpaceBioSpace · Wed, 05 Aug 2026 03:09:09 GMTLeads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise - The Manila TimesThe Manila Times · Mon, 03 Aug 2026 03:56:06 GMTFDA Clears Ractigen IND Application for Novel saRNA Candidate in Proliferative Vitreoretinopathy - Contract PharmaContract Pharma · Fri, 31 Jul 2026 14:54:44 GMTDyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD) - Yahoo Finance SingaporeYahoo Finance Singapore · Tue, 28 Jul 2026 11:30:00 GMTHumacyte Plans First Human Study of Bioengineered Vessel in Heart Bypass - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT